Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Ian Godsland

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Procedures

Glucose Tolerance Test

Disorders

Concepts & Ideas

Physiology

Carbohydrate Metabolism

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
31
Stevenson, John
20
Walton, Christopher
13
Johnston, Desmond
11
Leyva, Francisco
9
Coats, Andrew
8
Anker, Stefan
7
Flanagan, D E H
7
Proudler, Anthony
6
Phillips, David
5
Lees, Belinda
5
Swan, JW
5
Anyaoku, Victor
5
Cockington, Richard
5
Crook, David
4
Doehner, Wolfram

Sign-in to see all Coauthors

Publications

TOP 3
Salpea Klelia D; Gable David R; Cooper Jackie A; Stephens Jeffrey W; Hurel Steven J; Ireland Helen A; Feher Michael D; Godsland Ian F; Humphries Steve E
The effect of WNT5B IVS3C>G on the susceptibility to type 2 diabetes in UK Caucasian subjects.
Atta Maria; Crook David; Shafique Faria; Johnston Desmond G; Godsland Ian F
Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II.
Godsland Ian F; Johnston Desmond G
Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Ian Godsland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Salpea Klelia D; Gable David R; Cooper Jackie A; Stephens Jeffrey W; Hurel Steven J; Ireland Helen A; Feher Michael D; Godsland Ian F; Humphries Steve E
The effect of WNT5B IVS3C>G on the susceptibility to type 2 diabetes in UK Caucasian subjects.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(2):140-5.
2008: Atta Maria; Crook David; Shafique Faria; Johnston Desmond G; Godsland Ian F
Procoagulant activities of plasma factor VIIc and factor Xc are positively and independently associated with concentrations of the high-density lipoprotein apolipoprotein, apo A-II.
Thrombosis and haemostasis 2008;100(3):391-6.
2008: Godsland Ian F; Johnston Desmond G
Co-associations between insulin sensitivity and measures of liver function, subclinical inflammation, and hematology.
Metabolism: clinical and experimental 2008;57(9):1190-7.
2008: Elkeles Robert S; Godsland Ian F; Feher Michael D; Rubens Michael B; Roughton Michael; Nugara Fiona; Humphries Steve E; Richmond William; Flather Marcus D;
Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study.
European heart journal 2008;29(18):2244-51.
2008: Langley Ruth E; Godsland Ian F; Kynaston Howard; Clarke Noel W; Rosen Stuart D; Morgan Rachel C; Pollock Philip; Kockelbergh Roger; Lalani El-Nasir; Dearnaley David; Parmar Mahesh; Abel Paul D
Early hormonal data from a multicentre phase II trial using transdermal oestrogen patches as first-line hormonal therapy in patients with locally advanced or metastatic prostate cancer.
BJU international 2008;102(4):442-5.
2008: Yee Michael S; Pavitt Darrell V; Tan Tira; Venkatesan Soundararajan; Godsland Ian F; Richmond William; Johnston Desmond G
Lipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysis.
Journal of lipid research 2008;49(6):1364-71.
2008: Elkeles Robert S; Godsland Ian F; Rubens Michael B; Feher Michael D; Nugara Fiona; Flather Marcus D
The progress of coronary heart disease in Type 2 diabetes as measured by coronary calcium score from electron beam computed tomography (EBCT): the PREDICT study.
Atherosclerosis 2008;197(2):777-83.
2007: Laspa E; Christen A; Efstathiadou Z; Johnston D G; Godsland I F
Long-term changes and variability in diabetes risk factors prior to the development of impaired glucose homeostasis.
Diabetic medicine : a journal of the British Diabetic Association 2007;24(11):1269-78.
2007: Christen Annette; Efstathiadou Zoe; Laspa Eleni; Johnston Desmond G; Godsland Ian F
Rate of change and instability in body mass index, insulin resistance, and lipid metabolism as predictors of atherosclerotic vascular disease.
The Journal of clinical endocrinology and metabolism 2007;92(10):3780-7.
2007: Godsland Ian F; Johnston Desmond G; Chaturvedi Nishi
Mechanisms of disease: lessons from ethnicity in the role of triglyceride metabolism in ischemic heart disease.
Nature clinical practice. Endocrinology & metabolism 2007;3(7):530-8.
2007: Kousta Eleni; Lawrence Natasha J; Godsland Ian F; Penny Anna; Anyaoku Victor; Millauer Barbara A; Robinson Stephen; Johnston Desmond G; McCarthy Mark I
Early metabolic defects following gestational diabetes in three ethnic groups of anti-GAD antibodies negative women with normal fasting glucose.
Hormones (Athens, Greece) 2007;6(2):138-47.
2007: Flanagan Daniel E; Vaile Julian C; Petley Graham W; Phillips David I; Godsland Ian F; Owens Phillip; Moore Vivienne M; Cockington Richard A; Robinson Jeffrey S
Gender differences in the relationship between leptin, insulin resistance and the autonomic nervous system.
Regulatory peptides 2007;140(1-2):37-42.
2006: Godsland I F; Elkeles R S; Feher M D; Nugara F; Rubens M B; Richmond W; Khan M; Donovan J; Anyaoku V; Flather M D;
Coronary calcification, homocysteine, C-reactive protein and the metabolic syndrome in Type 2 diabetes: the Prospective Evaluation of Diabetic Ischaemic Heart Disease by Coronary Tomography (PREDICT) Study.
Diabetic medicine : a journal of the British Diabetic Association 2006;23(11):1192-200.
2006: de Rooij Susanne R; Painter Rebecca C; Phillips David I W; Osmond Clive; Michels Robert P J; Godsland Ian F; Bossuyt Patrick M M; Bleker Otto P; Roseboom Tessa J
Impaired insulin secretion after prenatal exposure to the Dutch famine.
Diabetes care 2006;29(8):1897-901.
2006: Flanagan D E; Holt R I G; Owens P C; Cockington R J; Moore V M; Robinson J S; Godsland I F; Phillips D I W
Gender differences in the insulin-like growth factor axis response to a glucose load.
Acta physiologica (Oxford, England) 2006;187(3):371-8.
2006: Godsland Ian F; Agbaje Olorunsola F; Hovorka Roman
Evaluation of nonlinear regression approaches to estimation of insulin sensitivity by the minimal model with reference to Bayesian hierarchical analysis.
American journal of physiology. Endocrinology and metabolism 2006;291(1):E167-74.
2006: Kousta E; Efstathiadou Z; Lawrence N J; Jeffs J A R; Godsland I F; Barrett S C; Doré C J; Penny A; Anyaoku V; Millauer B A; Cela E; Robinson S; McCarthy M I; Johnston D G
The impact of ethnicity on glucose regulation and the metabolic syndrome following gestational diabetes.
Diabetologia 2006;49(1):36-40.
2006: Jeffs James A R; Godsland Ian F; Johnston Desmond G
Less than 50% of variation in HDL cholesterol between and within individuals, is explained by established predictors.
Atherosclerosis 2006;184(1):178-87.
2005: Godsland I F
Oestrogens and insulin secretion.
Diabetologia 2005;48(11):2213-20.
2005: Doehner Wolfram; Rauchhaus Mathias; Ponikowski Piotr; Godsland Ian F; von Haehling Stephan; Okonko Darlington O; Leyva Francisco; Proudler Anthony J; Coats Andrew J S; Anker Stefan D
Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure.
Journal of the American College of Cardiology 2005;46(6):1019-26.
2005: Tillin T; Forouhi N; Johnston D G; McKeigue P M; Chaturvedi N; Godsland I F
Metabolic syndrome and coronary heart disease in South Asians, African-Caribbeans and white Europeans: a UK population-based cross-sectional study.
Diabetologia 2005;48(4):649-56.
2005: Godsland I F; Crook D; Proudler A J; Stevenson J C
Hemostatic risk factors and insulin sensitivity, regional body fat distribution, and the metabolic syndrome.
The Journal of clinical endocrinology and metabolism 2005;90(1):190-7.
2004: Godsland Ian F; Bruce Raymond; Jeffs James A R; Leyva Francisco; Walton Christopher; Stevenson John C
Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study.
International journal of cardiology 2004;97(3):543-50.
2004: Elkeles R S; Feher M D; Flather M D; Godsland I F; Nugara F; Richmond W; Rubens M B; Wang D;
The association of coronary calcium score and conventional cardiovascular risk factors in Type 2 diabetic subjects asymptomatic for coronary heart disease (The PREDICT Study).
Diabetic medicine : a journal of the British Diabetic Association 2004;21(10):1129-34.
2004: Godsland I F; Jeffs J A R; Johnston D G
Loss of beta cell function as fasting glucose increases in the non-diabetic range.
Diabetologia 2004;47(7):1157-66.
2004: Felton C V; Stevenson J C; Godsland I F
Erythrocyte-derived measures of membrane lipid composition in healthy men: associations with arachidonic acid at low to moderate but not high insulin sensitivity.
Metabolism: clinical and experimental 2004;53(5):571-7.
2004: Godsland I F; Manassiev N A; Felton C V; Proudler A J; Crook D; Whitehead M I; Stevenson J C
Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.
Clinical endocrinology 2004;60(5):541-9.
2004: Godsland Ian F
Biology: risk factor modification by OCs and HRT lipids and lipoproteins.
Maturitas 2004;47(4):299-303.
2003: Godsland Ian F
The minimal model: an evolving methodology.
Clinical science (London, England : 1979) 2003;105(5):531-2.
2003: Kousta Eleni; Lawrence Natasha J; Godsland Ian F; Penny Anna; Anyaoku Victor; Millauer Barbara A; Cela Ester; Johnston Desmond G; Robinson Stephen; McCarthy Mark I
Insulin resistance and beta-cell dysfunction in normoglycaemic European women with a history of gestational diabetes.
Clinical endocrinology 2003;59(3):289-97.
2003: Jolly M C; Hovorka R; Godsland I; Amin R; Lawrence N; Anyaoku V; Johnston D; Robinson S
Relation between insulin kinetics and insulin sensitivity in pregnancy.
European journal of clinical investigation 2003;33(8):698-703.
2002: Manassiev N A; Godsland I F; Crook D; Proudler A J; Whitehead M I; Stevenson J C
Effect of postmenopausal oestradiol and dydrogesterone therapy on lipoproteins and insulin sensitivity, secretion and elimination in hysterectomised women.
Maturitas 2002;42(3):233-42.
2002: Doehner Wolfram; Rauchhaus Mathias; Godsland Ian F; Egerer Karl; Niebauer Josef; Sharma Rakesh; Cicoira Mariantonietta; Florea Viorel G; Coats Andrew J S; Anker Stefan D
Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha.
International journal of cardiology 2002;83(1):73-81.
2002: Flanagan D E H; Pratt E; Murphy J; Vaile J C; Petley G W; Godsland I F; Kerr D
Alcohol consumption alters insulin secretion and cardiac autonomic activity.
European journal of clinical investigation 2002;32(3):187-92.
2001: Doehner W; Pflaum C D; Rauchhaus M; Godsland I F; Egerer K; Cicoira M; Florea V G; Sharma R; Bolger A P; Coats A J; Anker S D; Strasburger C J
Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia.
European journal of endocrinology / European Federation of Endocrine Societies 2001;145(6):727-35.
2001: Godsland I F; Walton C
Maximizing the success rate of minimal model insulin sensitivity measurement in humans: the importance of basal glucose levels.
Clinical science (London, England : 1979) 2001;101(1):1-9.
2001: Godsland I F
Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000.
Fertility and sterility 2001;75(5):898-915.
2001: Doehner W; Godsland I F; Anker S D
Vascular effect of insulin in endothelial dysfunction.
Journal of the American College of Cardiology 2001;37(2):689.
2001: Godsland I F; Rosankiewicz J R; Proudler A J; Johnston D G
Plasma total homocysteine concentrations are unrelated to insulin sensitivity and components of the metabolic syndrome in healthy men.
The Journal of clinical endocrinology and metabolism 2001;86(2):719-23.
2000: Godsland I F; Winkler U; Lidegaard O; Crook D
Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms.
Drugs 2000;60(4):721-869.
2000: Spencer C P; Godsland I F; Cooper A J; Ross D; Whitehead M I; Stevenson J C
Effects of oral and transdermal 17beta-estradiol with cyclical oral norethindrone acetate on insulin sensitivity, secretion, and elimination in postmenopausal women.
Metabolism: clinical and experimental 2000;49(6):742-7.
2000: Flanagan D E; Moore V M; Godsland I F; Cockington R A; Robinson J S; Phillips D I
Alcohol consumption and insulin resistance in young adults.
European journal of clinical investigation 2000;30(4):297-301.
2000: Flanagan D E; Moore V M; Godsland I F; Cockington R A; Robinson J S; Phillips D I
Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis.
American journal of physiology. Endocrinology and metabolism 2000;278(4):E700-6.
2000: Zoratti R; Godsland I F; Chaturvedi N; Crook D; Crook D; Stevenson J C; McKeigue P M
Relation of plasma lipids to insulin resistance, nonesterified fatty acid levels, and body fat in men from three ethnic groups: relevance to variation in risk of diabetes and coronary disease.
Metabolism: clinical and experimental 2000;49(2):245-52.
2000: Leyva F; Rauchhaus M; Anker S D; Proudler A J; Godsland I F; Stiefel P; Coats A J; Poole-Wilson P A; Stevenson J C
Non-invasive assessment of vascular function; paradoxical vascular response to intravenous glucose in coronary heart disease.
European heart journal 2000;21(1):39-44.
1999: Leyva F; Chua T P; Godsland I F; Coats A J; Anker S D
Loss of the normal coupling between the anaerobic threshold and insulin sensitivity in chronic heart failure.
Heart (British Cardiac Society) 1999;82(3):348-51.
1999: Flanagan D E; Moore V M; Godsland I F; Cockington R A; Robinson J S; Phillips D I
Reduced foetal growth and growth hormone secretion in adult life.
Clinical endocrinology 1999;50(6):735-40.
1999: Flanagan D E; Vaile J C; Petley G W; Moore V M; Godsland I F; Cockington R A; Robinson J S; Phillips D I
The autonomic control of heart rate and insulin resistance in young adults.
The Journal of clinical endocrinology and metabolism 1999;84(4):1263-7.
1998: Leyva F; Anker S D; Godsland I F; Teixeira M; Hellewell P G; Kox W J; Poole-Wilson P A; Coats A J
Uric acid in chronic heart failure: a marker of chronic inflammation.
European heart journal 1998;19(12):1814-22.
1998: Godsland I F; Leyva F; Walton C; Worthington M; Stevenson J C
Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC-1).
Journal of internal medicine 1998;244(1):33-41.
1998: Leyva F; Godsland I F; Ghatei M; Proudler A J; Aldis S; Walton C; Bloom S; Stevenson J C
Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(6):928-33.
1998: Leyva F; Wingrove C S; Godsland I F; Stevenson J C
The glycolytic pathway to coronary heart disease: a hypothesis.
Metabolism: clinical and experimental 1998;47(6):657-62.
1998: Crook D; Godsland I
Safety evaluation of modern oral contraceptives. Effects on lipoprotein and carbohydrate metabolism.
Contraception 1998;57(3):189-201.
1998: Wingrove C S; Garr E; Godsland I F; Stevenson J C
17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells.
Biochimica et biophysica acta 1998;1406(2):169-74.
1998: Leyva F; Godsland I F; Worthington M; Walton C; Stevenson J C
Factors of the metabolic syndrome: baseline interrelationships in the first follow-up cohort of the HDDRISC Study (HDDRISC-1). Heart Disease and Diabetes Risk Indicators in a Screened Cohort.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(2):208-14.
1997: Spencer C P; Godsland I F; Stevenson J C
Is there a menopausal metabolic syndrome?
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 1997;11(5):341-55.
1997: Swan J W; Anker S D; Walton C; Godsland I F; Clark A L; Leyva F; Stevenson J C; Coats A J
Insulin resistance in chronic heart failure: relation to severity and etiology of heart failure.
Journal of the American College of Cardiology 1997;30(2):527-32.
1997: Leyva F; Anker S; Swan J W; Godsland I F; Wingrove C S; Chua T P; Stevenson J C; Coats A J
Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure.
European heart journal 1997;18(5):858-65.
1997: Aitman T J; Godsland I F; Farren B; Crook D; Wong H J; Scott J
Defects of insulin action on fatty acid and carbohydrate metabolism in familial combined hyperlipidemia.
Arteriosclerosis, thrombosis, and vascular biology 1997;17(4):748-54.
1997: Crook D; Godsland I F; Hull J; Stevenson J C
Hormone replacement therapy with dydrogesterone and 17 beta-oestradiol: effects on serum lipoproteins and glucose tolerance during 24 month follow up.
British journal of obstetrics and gynaecology 1997;104(3):298-304.
1996: Proudler A J; Godsland I F; Bruce R; Seed M; Wynn V
Lipid and carbohydrate metabolic risk markers for coronary heart disease and blood pressure in healthy non-obese premenopausal women of different racial origins in the United Kingdom.
Metabolism: clinical and experimental 1996;45(3):328-33.
1996: Godsland I F
Interaction of oral contraceptive use with the effects of age, exercise habits and other cardiovascular risk modifiers on metabolic risk markers.
Contraception 1996;53(1):9-16.
1995: Walton C; Lees B; Crook D; Godsland I F; Stevenson J C
Relationships between insulin metabolism, serum lipid profile, body fat distribution and blood pressure in healthy men.
Atherosclerosis 1995;118(1):35-43.
1995: Walton C; Lees B; Crook D; Worthington M; Godsland I F; Stevenson J C
Body fat distribution, rather than overall adiposity, influences serum lipids and lipoproteins in healthy men independently of age.
The American journal of medicine 1995;99(5):459-64.
1995: Godsland I F; Crook D; Devenport M; Wynn V
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Contraception 1995;52(3):143-9.
1995: Godsland I F; Crook D; Stevenson J C; Collins P; Rosano G M; Lees B; Sidhu M; Poole-Wilson P A
Insulin resistance syndrome in postmenopausal women with cardiological syndrome X.
British heart journal 1995;74(1):47-52.
1995: Proudler A J; Crook D; Godsland I F; Collins P; Rosano G M; Stevenson J C
Serum angiotensin-I-converting enzyme activity in women with cardiological syndrome X: relation to blood pressure and lipid and carbohydrate metabolic risk markers for coronary heart disease.
The Journal of clinical endocrinology and metabolism 1995;80(2):696-9.
1994: Swan J W; Walton C; Godsland I F; Clark A L; Coats A J; Oliver M F
Insulin resistance in chronic heart failure.
European heart journal 1994;15(11):1528-32.
1994: Bruce R; Godsland I; Walton C; Crook D; Wynn V
Associations between insulin sensitivity, and free fatty acid and triglyceride metabolism independent of uncomplicated obesity.
Metabolism: clinical and experimental 1994;43(10):1275-81.
1994: Godsland I F; Crook D
Update on the metabolic effects of steroidal contraceptives and their relationship to cardiovascular disease risk.
American journal of obstetrics and gynecology 1994;170(5 Pt 2):1528-36.
1994: Proudler A J; Godsland I F; Stevenson J C
Insulin propeptides in conditions associated with insulin resistance in humans and their relevance to insulin measurements.
Metabolism: clinical and experimental 1994;43(4):446-9.
1994: Swan J W; Walton C; Godsland I F
Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure.
Clinical science (London, England : 1979) 1994;86(3):317-22.
1994: Ley C J; Swan J; Godsland I F; Walton C; Crook D; Stevenson J C
Insulin resistance, lipoproteins, body fat and hemostasis in nonobese men with angina and a normal or abnormal coronary angiogram.
Journal of the American College of Cardiology 1994;23(2):377-83.
1994: Swan J W; Walton C; Godsland I F; Crook D; Oliver M F; Stevenson J C
Insulin resistance syndrome as a feature of cardiological syndrome X in non-obese men.
British heart journal 1994;71(1):41-4.
1994: Stevenson J C; Proudler A J; Walton C; Godsland I F
HRT mechanisms of action: carbohydrates.
International journal of fertility and menopausal studies 1994;39 Suppl 1():50-5.
1993: Crook D; Godsland I F; Worthington M; Felton C V; Proudler A J; Stevenson J C
A comparative metabolic study of two low-estrogen-dose oral contraceptives containing desogestrel or gestodene progestins.
American journal of obstetrics and gynecology 1993;169(5):1183-9.
1993: Godsland I F; Crook D; Worthington M; Proudler A J; Felton C; Sidhu M; Stevenson J C
Effects of a low-estrogen, desogestrel-containing oral contraceptive on lipid and carbohydrate metabolism.
Contraception 1993;48(3):217-27.
1993: Walton C; Godsland I F; Proudler A J; Wynn V; Stevenson J C
The effects of the menopause on insulin sensitivity, secretion and elimination in non-obese, healthy women.
European journal of clinical investigation 1993;23(8):466-73.
1993: Godsland I F; Gangar K; Walton C; Cust M P; Whitehead M I; Wynn V; Stevenson J C
Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy.
Metabolism: clinical and experimental 1993;42(7):846-53.
1993: Godsland I F; Felton C; Wynn V
Venous blood arterialization and parameters from the minimal models of glucose disappearance and post-hepatic insulin delivery.
Clinical science (London, England : 1979) 1993;85(1):89-95.
1993: Stevenson J C; Crook D; Godsland I F
Influence of age and menopause on serum lipids and lipoproteins in healthy women.
Atherosclerosis 1993;98(1):83-90.
1993: Stevenson J C; Crook D; Godsland I F; Lees B; Whitehead M I
Oral versus transdermal hormone replacement therapy.
International journal of fertility and menopausal studies 1993;38 Suppl 1():30-5.
1992: Walton C; Godsland I F; Proudler A J; Felton C V; Wynn V
An apparently anomalous relationship between insulin and C-peptide concentrations in their initial response to intravenous glucose.
Metabolism: clinical and experimental 1992;41(11):1210-4.
1992: Walton C; Godsland I F; Proudler A J; Felton C V; Wynn V
Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men.
The Journal of clinical endocrinology and metabolism 1992;75(1):170-5.
1992: Godsland I F; Crook D; Wynn V
Clinical and metabolic considerations of long-term oral contraceptive use.
American journal of obstetrics and gynecology 1992;166(6 Pt 2):1955-63.
1992: Walton C; Godsland I F; Proudler A J; Felton C; Wynn V
Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity.
The American journal of physiology 1992;262(5 Pt 1):E755-62.
1992: Godsland I F; Walton C; Crook D; Wynn V
Insulin resistance--modelling studies.
European journal of epidemiology 1992;8 Suppl 1():136-8.
1992: Bruce R; Godsland I; Stevenson J; Devenport M; Borth F; Crook D; Ghatei M; Whitehead M; Wynn V
Danazol induces resistance to both insulin and glucagon in young women.
Clinical science (London, England : 1979) 1992;82(2):211-7.
1992: Godsland I F; Walton C; Felton C; Proudler A; Patel A; Wynn V
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
The Journal of clinical endocrinology and metabolism 1992;74(1):64-70.
1991: Crook D; Montgomery J C; Godsland I F; Devenport M; Marenah C B; Studd J W; Wynn V
Lipid and carbohydrate metabolism in premenopausal women given subdermal estradiol implants.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1991;23(4):174-7.
1991: Godsland I F; Crook D; Wynn V
Coronary heart disease risk markers in users of low-dose oral contraceptives.
The Journal of reproductive medicine 1991;36(3 Suppl):226-37.
1991: Crook D; Godsland I F; Wynn V
Oral contraceptives and metabolic risk markers for coronary heart disease.
International journal of fertility 1991;36 Suppl 1():38-46.
1990: Godsland I F; Crook D; Simpson R; Proudler T; Felton C; Lees B; Anyaoku V; Devenport M; Wynn V
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
The New England journal of medicine 1990;323(20):1375-81.
1990: Godsland I F; Crook D; Wynn V
Low-dose oral contraceptives and carbohydrate metabolism.
American journal of obstetrics and gynecology 1990;163(1 Pt 2):348-53.

Sign-in to see more